Bioequivalence of Oral Drug Products in the Healthy and Special Populations: Assessment and Prediction Using a Newly Developed In Vitro System “BE Checker”

In order to assess and predict the bioequivalence (BE) of oral drug products, a new in vitro system “BE checker” was developed, which reproduced the environmental changes in the gastrointestinal (GI) tract by changing the pH, composition, and volume of the medium in a single chamber. The dissolution...

Descripción completa

Detalles Bibliográficos
Autores principales: Masada, Takato, Takagi, Toshihide, Minami, Keiko, Kataoka, Makoto, Izutsu, Ken-ichi, Matsui, Kazuki, Yamashita, Shinji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8398564/
https://www.ncbi.nlm.nih.gov/pubmed/34452100
http://dx.doi.org/10.3390/pharmaceutics13081136

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8398564/
https://www.ncbi.nlm.nih.gov/pubmed/34452100
http://dx.doi.org/10.3390/pharmaceutics13081136

Ejemplares similares